Market Research Blog

According to the latest research by Future Market Insights, Cognitive neuroscience market is set to witness a 4.6% CAGR growth during the year 2021-2031. The market has been a moderately competitive market developing at a rapid rate and is anticipated to observe lucrative growth with rising cases of neurological disorders that include Parkinson’s, Alzheimer’s diseases, and other dementias are projected to drive the market growth.

Also, neuroscience-based initiatives by government bodies, high influencing factors, such as current brain mapping research and investigation ventures, and technological advancements in algorithms and tools that are applied in neuroscience space, are anticipated to propel the market growth.

What is Driving Demand for Cognitive Neuroscience?

The rising number of brain-related disorders and the number of advanced healthcare systems are certain driving factors for the market.

Furthermore, key factor that has accelerated the research studies in this arena is the growth in the number of various malignant CNS disorders such as Parkinsonism and Alzheimer’s disease. As geriatric population is prone to various central nervous systems associated disorders such as schizophrenia, Alzheimer’s, and Parkinsonism, with growth in the older population, this market is anticipated to witness lucrative growth.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14154

Also, constant launch of novel products by major participants in the market to fight several neurological disorders is anticipated to increase Y-O-Y growth of this market.

Surge in Number of Deaths Due to Neurological Disorders likely to boost the Cognitive Neuroscience Sales

The rising incidents of neurological disorders, which include Parkinson’s, Alzheimer’s, and other brain-related disorders are expected to encourage participants in the cognitive neuroscience market to help combat such disorders. In 2018, over one hundred thousand people died because of Alzheimer’s in the United States.

Also, rising number of neurological disorder cases are expected to increase the number of deaths occurring due to these disorders. Moreover, the government bodies are growing the medical expenditure to support development of medical facilities in neuroscience leading to development of the market.

US and Canada Cognitive Neuroscience Market Outlook

United States and Canada led the Cognitive Neuroscience market. U.S. Cognitive Neuroscience market is anticipated to witness noteworthy growth owing the existence of neuroscience based research organizations as well as availability of advanced healthcare systems.

Moreover, large organizations and many neuroscientists are spreading knowledge and awareness through programs concerning the brain system in government as well public offices. Also, rise in number of deaths associated with neurological disorders is one of the key factors for the development of the market in U.S.

Europe Demand Outlook for Cognitive Neuroscience

Europe is second leading market and is anticipated to register a significant growth because of the growing burden of neurological diseases in Europe and the availability of large manufacturers in the region.

In 2017, as per ‘The burden of neurological diseases in Europe’ report, over a million deaths occurred in the WHO European region due to neurological diseases. It lead towards a high demand for the growth of the cognitive neuroscience market.

Who are the Key Manufacturers and Suppliers of Cognitive Neuroscience?

Some of the leading manufacturers and suppliers of cognitive neuroscience include

• Siemens Healthineers
• Scientifica Ltd.
• Alpha Omega Inc.
• GE Healthcare
• Biobserve GmbH
• NeuroNexus Technology
• Laserglow Technologies
• Kendall Research Systems LLC and others.

The cognitive neuroscience market is moderately competitive, with the existence of a large number of players in global markets. Key players in the market are focusing on mergers & acquisitions and partnerships with other small players. Moreover, companies are also concentrating on research activities and new product launches.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Cognitive Neuroscience Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14154

Key Segments

By Type:

• Magnetic Resonance Imaging (MRI)
• Functional Magnetic Resonance Imaging (fMRI)
• Positron Emission Tomography (PET)
• Magnetoencephalography (MEG)
• Encephalography (EEC)
• Near Infrared Spectroscopy (NIRS)
• Single Photon Emission Computed Tomography (SPECT)

By Application:

• Brain Imaging
• Neurological Research
• Neurological Disorders
• Psychiatry

By End User:

• Pharmaceutical Companies
• Clinical & Research Laboratories
• Academic Research Institutes
• Hospitals & Pathology Laboratories
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14155

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

• CTK Biotech Inc.
• Biopanda Reagents Ltd.
• Avecon Healthcare Pvt Ltd.
• Abbott
• Bio-Rad Laboratories Inc.
• Siemens Healthineers
• QIAGEN
• F. Hoffmann-La Roche AG and others.

The HBsAg Testing market is competitive, with the presence of a few major players. These global market players compete mainly on the basis of technological developments. Moreover, key players are investing greatly in the research and development to develop rapid and advanced diagnostic products.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

HBsAg Testing Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14155

Key Segments:

By Kit Type :

• Cassettes/Cards
• Strips

By Sample Type:

• Serum
• Plasma
• Whole Blood

By End User:

• Hospitals
• Clinics
• Diagnostic Centres
• Home Care
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, interlaminar device market is set to witness a growth 5.4% during the year 2021-2031. Interlaminar device normally relates to the disease defined by the compression of nerve roots and shrinking of the spinal canal due to many pathologic causes, further leads to symptoms such as pain with a tingling feeling, numbness, and weakness. Spinal stenosis can include the cervical, lumbar, or thoracic (rarely) spine.

What is Driving Demand for Interlaminar Device?

The growth for interlaminar device is driven by various factors including advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries.

Furthermore, key players across the globe focus on advancements in terms of technology to improve the interlaminar device efficacy and expanding their application in the market and assist with inventive growth opportunities. Furthermore, introducing unique product in the market allows businesses to acquire a competitive edge and increase product adoption.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14214

Which factors are likely to Augment Growth of Interlaminar Device Market?

The growth of interlaminar device is likely to be boosted by technological factors which benefits include a shorter hospital stay and recovery time, faster and longer-lasting relief from discomfort, better treatment adaptability, and adjacent layers are naturally moving.

For instance, in May 2018 Paradigm Spine disposable instrument kit coflex® Interlaminar stabilization gets FDA pre-market approval. Coflex® interlaminar stabilization is an exclusive posterior lumbar motion preservation solution which offers long-term outcomes for patients with moderate to severe spinal stenosis.

U.S. and Canada Interlaminar Device Market Outlook

The region of North America accounts for highest market share in the current scenario for interlaminar device. The increasing adoption and penetration of interlaminar device into US and Canada market is mainly due to  a rise in the number patients with spinal cord injury, better healthcare facilities, and organizations like the North American Spine Foundation all working to raise awareness and educate healthcare providers and public about different medical condition.

As per data published by National Spinal Cord Injury Statistical Center, in 2017, approximately 285,000 people in the U.S. are estimated to be suffering from spinal cord injuries.

Europe Demand Outlook for Interlaminar Device

The European region is set to witness a dominant demand for interlaminar device due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage are the major key factor to boost the growth in European region.

Some other factors are rising treatment rates for degenerative spine diseases, rising geriatric population, medical technological advances, and a growth in the demand for minimally invasive treatments are all contributing factors to this trend in Europe.

Who are the Key Manufacturers and Suppliers of Interlaminar Device?

The key companies operating in manufacturing and supply of interlaminar device market include

• NuVasive
• Life Spine
• Lanx acquired by BioMet
• X-Spine
• Pioneer Surgical
• Alphatec
• Paradigm Spine
• Spine Frontier
• Amedica Corp.
• Bioventus
• Camber Spine Technologies
• DePuy Synthes
• Implanet
• Mazor Robotics
• Meditech Spine.

The key players adopt growth strategies for product portfolio expansion by designing novel interlaminar device. The companies also have extensive distribution systems for effective sales revenue generation.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Interlaminar Device Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14214

Key Segments

By Product Type:

• Interspinous Distraction Devices
• Coflex Device

By Technology:

• Fusion and Fixation Technology
• Vertebral Compression Fracture Treatment
• Motion Preservation Technologies

By Type of Surgery:

• Open Surgery
• Minimally Invasive surgery

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

 

According to the latest research by FMI, portable MRI are set to witness a high growth of CAGR 6.8% during the year 2021-2031.

Portable MRI is an emerging tool during the COVID-19 pandemic. The introduction of low cost solutions in terms of portable MRI scanners is expected to enable new point-of-care and monitoring applications. With existing MRI scanners in centralized settings, accessibility and reduction of cost is primal.

Upcoming advancements in computational technology, hardware as well as expanding scanning-based technology industry in developing economies is set to effectively lead towards boosting sales of portable MRI.

Factors associated with the compatible applications of portable MRI in hospital environment and the reduced risk associated with lower magnetic strength of portable MRI are set to advance imaging services with expense mitigation, globally.

Portable MRI sales are expected to greater expansion over the forecast period owing to the strength of the factors mentioned above.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14215

What is Driving Demand for Portable MRI?

The demand for portable MRI is driven by the premise of expansive reach of MRI through cost reduction. The applications of portable MRI provide support in terms of cost, sitting and operational burdens which is directly applicable to benefitting the overall healthcare development by increasing the access to MRI examinations for a larger number of patients. Additionally, portable MRI yields a higher rate of use with varied applications.

Not to mention, in cases of acute neurological settings, the application of portable MRI will positively impact patient health with non-invasive and time-sensitive neuroimaging. The benefits of this approach can potentially be employed in the assessment of neurological injury in various medical setups, including environments with limited resources.

Which Factors are likely to Augment Growth of Portable MRI?

Technological advancements in terms of MRI scanners, especially specialty scanners has introduced a unique method of imaging. The costs associated with such scanners exhibited sub-optimal commercialization as compared to the prevailing models. The augmentative factor which provides leverage to portable MRI sales is the ease of access and potential for commercialization because of the advent of the COVID-19 pandemic.

U.S. and Canada Portable MRI Outlook

Introduction of COVID-19 pandemic over the globe impacted the magnetic resonance departments across the United States in terms of reduced procedure volume. The region of North America is expected to exhibit growth in terms of portable MRI sales over the forecast period. The growth is catalyzed by the increasing patient pool in the region as well globally, and rising awareness towards early diagnosis of diseases.

To quote health information provided by the Govt. of Canada on their website “44% of adults 20+ have at least 1 of 10 common chronic conditions”. Portable MRI demand in Canada is expected to increase over the forecast period owing to the rising prevalence of chronic diseases and growing geriatric population.

Europe Demand Outlook for Portable MRI

The region of Europe is projected to occupy a large share after North America in the adoption of portable MRI due to the rising prevalence of chronic diseases in the region, as well as increasing technological advancements, resulting in high demand for medical imaging devices.

The growth is also associated with the growing popularity of teleconsultation and teleradiology in the region, especially in countries like Germany. Demand of portable MRI in the region is lucrative and based upon the premise to fight cancer by employing cost-efficient and accessible diagnostic imaging solutions.

Who are the Key Manufacturers and Suppliers of Portable MRI?

Key companies operating in manufacturing and supply of Portable MRI are

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Hyperfine
• Voxelgrids
• PrizMed Imaging.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Portable MRI market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14215

Key Segments

By Type:

• Superconducting-magnet-based portable MRI
• Electromagnet-based portable MRI
• Permanent-magnet-based portable MRI

By Imaging:

• General Brain Imaging
• Headaches
• Stroke
• Non-Specific Muscular Weakness
• Encephalopathy

By Facility

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Research Laboratories

By Region:

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • BENELUX
  • Russia
• South Asia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Rest of South Asia
• East Asia

• China
• Japan
• South Korea

• Middle East and Africa
  • GCC Countries
  • South Africa
  • Turkey

 

According to the latest research by FMI, EMG biosensors market is set to experience steady growth during the year 2021-2031. With increasing importance of continuous health monitoring, the market according to research conducted by Fact.MR will see a steady growth over the forecast period of 2021-2031 with a CAGR of around 6.7%.

What is Driving the Demand for EMG Biosensors market?

Skeletal muscles in the human body carry out their function of contracting and relaxing with help of electrical signals directed by the brain. EMG or Electromyograph is type of device that measure this electrical activity.

Any variation in these patterns can point to a disturbance in the standard muscular function. This activity can be widely measured and analysed in two forms; pattern recognition and signal intensity.

Abnormal pattern in the former can indicate towards a potential muscular complication. The later, however, helps in determining the strength of the electrical signals reaching the muscles from the brain. Low signal points towards a probable electrical conduction issue in these skeletal muscles and vice versa.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14216

These biosensors apart from EMG have diversity in their application, ranging from monitoring of heart rate, neural study and dermal study. This is an important factor in driving this market towards an optimistic future.

Growing awareness of continuous health monitoring is another crucial factor in driving this market ahead. This has recently gained more popularity among the athletes. Many athletes use this EMG biosensors to closely monitor their health, and notifies them in case of health concerns. This early detection will help athletes perform better and help them stay ahead of their game.

With technological advancements, biosensor technology is integrated in smart bands, smart watches, and smart rings which help monitor health parameters on the move 24/7. Although this may open up new avenues, but data accuracy is one of the concern which is likely to have negative impact on the market growth.

Development of Novel EMG Biosensors to Create lucrative Growth Opportunities.

According to article published by American Institute of Physics in their APL Materials journal (24 August 2021) use of nanocomposites made from materials like gold and silver which can be used in EMG biosensors.

Textile-based and affordable silver (Ag) micro-flakes were fabricated and then gold (Au) nano-particles were electrochemically deposited on the Ag. This process helped the researchers in increasing the bioavailability, biocompatibility and surface area of the particles.

It was inferred that the signals received during the myography were detected with more ease and accuracy than the normal biosensors. Bicep and finger movements were recorded to show the most sensitivity among other movements. Discoveries like these venturing into novel avenues to improve existing infrastructure will reinforce the growth of EMG biosensors market.

U.S and Canada EMG Biosensors Market

Advanced health edifice combined with standardized policies will help the U.S market towards a growth. The presence of major players will certainly prove beneficial for the market as with increasing research in finding out various applications of these bioreactors will certainly impact the market positively.

Apart from this, Washington Post reported that USA has the highest number of athletes in the Olympics. As continuous health monitoring plays an important role in athlete’s career, the presence of large number of athletes will positively drive the sales of EMG biosensors in this region.

Europe EMG Biosensors Market

Europe is the second most lucrative market owing to the European Union’s efforts to setup a novel technique in health monitoring. This technique is known as the Surface ElectroMyoGraphy for the Non-Invasive Assessment of muscles or SENIAM. EU’s Biomedical Health and Research P7rogramme has setup this technique. This technique consists of a set of simulation models for education and testing, a set of test signals, eight books, publications and a European network for SEMG: the SENIAM club.

Some of the Key player operating in Europe include; TMSi (Netherlands), Bitbrain Technologies (Spain), and LUX Wireless Biosignals S.A (Portugal).

Who are the key Manufacturing Supplying Companies in EMG Biosensors Market?

Key manufacturers and suppliers in the market are

• Biometrics Ltd. (US)
• Delsys Incorporated (US)
• Butler Technologies (Ireland)
• iMotions (Denmark)
• EB Neuro S.p.A. (Italy)
• Compumedics NeuroScan (United States)
• OpenBCI (US)
• Ceribell Inc. (United States) and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

EMG Biosensors Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14216

Key Segment

By Type:

• Surface Biosensors
• Intramuscular Biosensors

By Technique:

• Signal Intensity Registration
• Pattern Recognition

By End User:

• Hospitals and Clinics
• Ambulatory Health Clinics
• Academic and Research Centres

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

The digital pathology market has witnessed notable changes in terms of product innovation. One of the major reasons behind this is the scope of cloud integration with pathology outcomes in laboratory operations. According to a recent report by Future Market Insights, the global digital pathology market was valued at USD 6.19 Bn in 2021 and is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031).

According to the recent research by Future Market Insights, the functional electrical stimulation market is set to witness 8.6% growth during the forecast period from 2021 to 2031. The rising incidences of injury to the central nervous system lead to enhance functional electrical stimulation market during the forecast period from 2021 to 2031. Therefore, there will be significant growth seen in the functional electrical stimulation market.

What is Driving the Demand for Functional Electrical stimulation?

The functional electrical stimulation market is driven by various factors such as rising musculoskeletal disorders, advancement in the technological field such as medical science, the rising importance of pain management therapies in different fields of medicines, and the increasing number of physiotherapists for the disorders of muscle stimulators helps decrease pain, decrease discomfort, restore muscle tone, and rehabilitate various parts of the body.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14217

Also, the unhealthy diet and lack of physical activities and exercise tend to drive the demand for functional electrical stimulation soon.

Rising Prevalence of Musculoskeletal Disorders Likely to Propel the Growth of Functional electrical stimulation Market

The prevalence of musculoskeletal disorders is rising globally due to unhealthy diet and lack of physical activity which leads to obesity and musculoskeletal disorders.

According to WHO data of February 2021, a total of 1.71 billion people were suffering from musculoskeletal conditions worldwide. Among which low back pain causes the highest burden with a prevalence of 568 million people suffering from the condition globally.

Thus, the demand for functional electrical stimulation will increase significantly with the increasing prevalence of musculoskeletal disorders shortly.

U.S. and Canada Functional Electrical Stimulation Market Outlook

Obesity is related to nervous system disorders and can lead to the condition of stroke also where the blood stops flowing to the brain. In America, the prevalence of obesity is rising due to changing lifestyles such as having unhealthy diet choices and changing sleep schedules.

For instance, according to CDC, the prevalence of obesity increases from 30.5% to 42.4% from 2000 to 2018.

Therefore, the demand for functional electrical stimulation will increase during the forecast period from 2021 to 2031.

Europe Demand Outlook for Functional Electrical Stimulation

The prevalence of the musculoskeletal disorder is high in the region that has a direct positive impact on the electrical stimulation market. For instance, Poland and Hungary are the two European countries with the highest prevalence of musculoskeletal disorder with 6,737 and 6,697 per 100,000 population respectively.

Thus, with the rising musculoskeletal disorder, the demand for functional electrical stimulation also rises in the region.

Who are the Key Manufacturers and Suppliers of Functional Electrical Stimulation?

The key players of functional electrical stimulation include HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, and others.

The above companies follow certain strategies like merger & acquisition, getting FDA approval, and new product launches to be at the top position in the market. For instance, in May 2017, Ottobock collaborated with Bioness for the distribution of the new FES generation from Bioness.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Integrated Functional Electrical Stimulation Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14217

Key Segments

By Product Type:

• Wired Devices
• Wireless Devices

By Indication:

• Neurological Disorders
• Pain Management
• Musculoskeletal Disorders
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

 

According to latest research by FMI, gel implants will experience substantial growth with CAGR 3.1% during the forecast period 2021-2031. Increased demand for gel implants is expected to encounter due to the rising demand of cosmetology. Increasing awareness of cosmetology procedures is expected to present lucrative opportunities to the key players of this demand outlook in the near future.

The main factors driving the growth of the gel implants market include the increased focus on physical appearance and the increasing availability of inexpensive silicone cohesive breast implants. In addition, the increasing prevalence of breast cancer and the availability of a wide range of breast implants are driving the growth of the market.

For instance, according to the America Society of Plastic Surgeons, it was estimated that approximately 1,93,073 breast augmentation surgeries were performed in 2020.

Silicone gel implants were highly preferred by all the women seeking breast augmentation surgeries since they have higher quality in terms of appearance and firmness as compared to saline ones. Thus, the increased preference of the target population is expected to increase the demand during the forecast period.

Breast augmentations are becoming increasingly popular in emerging markets. The main reasons for this are increased economic prosperity and disposable income amongst the working population, increased influence of the cosmetic and fashion industry, increased people’s awareness of the latest products and processes, and low business start-up costs.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14220

The growing prevalence of breast cancer is another key driver that is anticipated to propel the growth of the gel implants market. According to WHO, in the year 2020, the number of diagnosed cases of breast cancer were a staggering 2.3 million, and around 685,000 deaths occurred due to breast cancer, globally.

The increasing prevalence of breast cancer has led to an increase in the number of women undergoing breast mastectomy, that is, breast augmentation. Surgical removal of one or both breasts, leading to more women undergoing breast augmentation. According to the American Society of Plastic Surgeons, approximately 36,367 women underwent breast augmentation surgeries as a preventative measure against breast cancer. Increased awareness amongst women about preventative procedures against cancer is another key driver of the gel implants market.

Prayasta: Using 3D Technology for Breast Augmentation

Bengaluru based start-up ‘Prayasta’ is reaching new heights in the breast augmentation industry. The company was established in 2017 and is developing a 3D printing technology to manufacture personalized breast implants for the target audience.

They have developed an in-house printer Silimax P250, from scratch to cater to the women who have to undergo mastectomy either due to suffering from breast cancer or as a preventative measure. The company wants to ensure the “one-to-one personalization” for all the women since every women’s body is different in structure, size, and shape so that they can provide the implant which is closest to its natural counterpart.

U.S. and Canada Gel Implants Demand Outlook

U.S. and Canada regions hold a large chunk of the gel implants market. The reason for such a high market share is due to the increased awareness of breast cancer, which is leading to many women opting for preventive mastectomy procedures.

Increased popularity and adoption of gel implants due to the higher efficacy of cohesive gel implants is expected to fuel the growth of this demand in the forecast period in this region.

For instance, on October 20, 2021, Sientra, Inc. announced that they have collaborated with a nonprofit organization ‘Mission Plasticos’ dedicating their venture to provide reconstructive surgical care to medically underserved and needy communities around the world with their program “ Reshaping Lives: Full Circle”.

Europe Gel Implants Demand Outlook

Europe holds a moderately high share in the global gel implants market. Factors such as the rising occurrence of breast cancer in Europe and the rise in breast cosmetic operations are likely to boost the market’s growth.

On the other hand, due to the disadvantages of breast implants, such as scarring or rippling, the market is anticipated to suffer a negative impact. In Europe, breast augmentation is the most popular cosmetic operation.

For instance, in April 2019, The German Federal Cabinet announced the initiation of a digital implant register for all the German patients to ensure the safety of all the patients undergoing implant surgeries.

Who are the Key Manufacturers of Gel Implants?

The key manufacturers of gel implants are

• Allergan Inc.
• Arion Laboratories
• Cereplas
• Establishment Labs
• Mentor Woldwide LLC (Johnson & Johnson Services Inc.)
• GC Aesthetics PLC
• Sientra Inc.
• Groupe Sebbin SAS
• Polytech Health & Aesthetics GmbH
• HansBiomed Co Ltd.
• Guangzhou Wanhe Plastic Materials
• Ideal Implant
• and Silimed.

On October 14, 2021, GC Aesthetics announced a new partnership with RepCa Medical, a Guatemalan distributor in Latin America. The partnership is aimed to provide their customers with the latest technology, quality, safety, innovation and support.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Gel Implants Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14220

Key Segments:

By Type:

• Cohesive Gel Implants
• Highly Cohesive Gel Implants
• Gummy Bear Gel Implants

By Shape:

• Round
• Anatomical
• Tear drop

By Indication:

• Cosmetic Surgery
• Reconstruction Surgery
• Preventive Surgery

By End-User:

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

 

Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market. According to the latest research by FMI, the global bone growth stimulators market is expected to account for US$ 1,387.7 Mn by the end of 2029. The bone growth stimulators market is estimated to grow at a CAGR of 5.2% through the forecast period 2019-2029. However, factors such as the high prices of devices and product recalls are expected to hamper the growth of the bone growth stimulators market.

Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world. Some of the most common sites of osteoporotic fractures are the spine, wrists, hips, and shoulders. Thus, the increasing population suffering from orthopaedic disease is creating high demand for bone growth stimulators. The cause of delayed bone healing and fractures is not known, however, it is creating a large economic impact on the market of bone growth stimulators.

According to the latest research by Future Market Insights, the Pulmonology Lasers Market will witness growth during 2021-2031. Any type of cancer is rapidly mutating and presenting a challenge for the researchers to keep up with these mutations and develop effective treatments for them.

Lung cancer being one of the concerning risers. Prevalence of this cancer is increasing day-by-day as per the European Union and the Cancer.org. This will directly affect research and development into lung cancer in finding ways to effectively treat it and hence boosting the market growth with a CAGR of around 12.4%.

What is Driving Demand for Pulmonology Lasers Market?

Pulmonary Lasers use thermal – ablation technique where cutting and coagulation properties is used to treat complication related to the airway tract. It can act as a palliative as well as curative therapy which relieves the obstructions in the airway caused due to various complications like neoplasms, tumours, lesions, etc.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14221

Most crucial driver of the market is that this laser therapy provides curative effect for lung cancer (early stage) as well as palliative care of central airway obstruction due to a number of malignancies.

Another associated factor is that the growing number of cancer prevalence is making researchers to find treatments competent enough to keep up with this mutating disease.

The ever changing epidemiology of cancer as a disease will definitely boost professionals to keep innovating in order to make detection as early as possible; and possibly boosting this market.

Needle-based Confocal Laser Endomicroscopy (nCLE) – A lung Cancer Detection Tool

It is very challenging to successfully diagnose peripheral lung cancer with traditional bronchoscope because some target lesions can be missed out. So, a BMJ Journal article explored the feasibility of a new microscopic laser needle in order to accurately detect the lesions present in the airway.

This new technique helps in visualising the site in real time to detect these lesions. This 2021 study concluded that, this imaging and laser combo is feasible, safe and allows real-time lung cancer lesion detection. Accurate distinguishing of airway parenchyma from lung cancer lesions was seen with the help of this guidance tool.

U.S. and Canada Pulmonology Lasers Market

As per Cancer.org, 235,760 new lung cancer cases and 131,880 deaths due to lung cancer are estimated in 2021 in the US. These statistics are definitely an ally to the market growth of pulmonology lasers in the country and will drive the market towards a positive side.

Authorities here are now focusing more on investments in R&D to improve the management and treatment of these lung cancer. This collectively makes US a front runner in the pulmonology lasers market in North America region.

Europe Pulmonology Lasers Market

According to data published by European Union, 312,000 European people get affected from lung cancer every year. Owing to this, demand for advanced and swift treatment along with early detection for lung cancer is increasing. Furthermore, the rising technological advancement and increasing investment in R&D is expected to drive the market growth during the forecast period.

Who are the Key Manufacturing and Supplying Companies in Pulmonology Lasers Market?

Key players:

• Quanta System
• Hyper Photonics
• Richard Wolf
• Lumenis
• Cook Medical
• Edap Tms
• Olympus Corporation
• EMS
• Cooltouch
• Convergent Laser Technologies
• AMS
• Jena Surgical
• Solar Laser Systems
• Potent Medical
• Candela Medical

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pulmonology Lasers Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14221

Key Segments

By Laser Type:

• Neodymium-doped Yttrium Aluminium Garnet (Nd-YAG)
• Photodynamic

By Indication:

• Bronchogenic Carcinoma
• Malignant Lesions
• Benign Tumours
• Neoplasms
• Haemorrhage
• Tracheal Stenosis
• Non-small Cell Lung Cancer
  •  carcinoid
  •  cystic carcinoma
  •  mucoepidermoid carcinoma
  •  endobronchial metastases

By End User:

• Hospitals
• Speciality Care Centres
• Academic and Research Institutions

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa